![\"Tumor](\"https:\/\/img.einpresswire.com\/large\/581248\/tumor-ablation-therapy-devices.jpeg#1024x302\")
<\/a><\/p>\nTumor Ablation Therapy Devices Global Market Report 2023 \u2013 Market Size, Trends, And Global Forecast 2023-2032<\/p>\n<\/div>\n<\/div>\n
The Business Research Company\u2019s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032<\/i><\/p>\n \u2014 The Business Research Company<\/p>\n<\/div>\n LONDON, GREATER LONDON , UK, December 8, 2023 \/EINPresswire.com<\/a>\/ — The tumor ablation therapy devices market has experienced rapid growth, escalating from $0.64 billion in 2023 to an anticipated $0.74 billion in 2024, reflecting an impressive Compound Annual Growth Rate (CAGR) of 15.8%. Poised for continued expansion, the tumor ablation therapy devices market is expected to reach $1.27 billion by 2028, maintaining a robust CAGR of 14.5%.<\/p>\n Tumor Ablation Therapy Devices Market Driver<\/a>: Escalating Cancer Incidence<\/p>\n A key driver fueling the growth of the tumor ablation therapy devices market is the increasing prevalence of cancer, a major global health concern. Cancer ranks as the second leading cause of death, contributing to approximately 1 in 6 deaths worldwide. Tumor ablation, a minimally invasive procedure, has gained prominence in treating various tumors, including those in the lungs, liver, kidneys, and bones. Notably, in 2023, the American Cancer Society Inc. reported an expected increase in new cancer cases in the US to 1,958,310, reinforcing the critical role of tumor ablation in cases where conventional treatments like chemotherapy or radiotherapy have proven ineffective.<\/p>\n Explore the Market with a Detailed Sample Report: Emerging Trend: Technology Advancements Enhance Treatment Efficacy<\/p>\n A prominent trend in the tumor ablation therapy devices market is the focus on technological advancements to improve the efficacy of procedures. Major industry players are investing in innovations aimed at reducing procedure duration, enhancing safety, minimizing radiation exposure, facilitating faster learning curves, and improving treatment outcomes. Examples include J&J Medicals’ NEUWAVE microwave ablation system, the first minimally invasive device capable of placing electrodes into cancer cells to elevate temperatures and eradicate cancer cells. Additionally, Compal Electronics introduced AblatePal, a radiofrequency ablation (RFA) system designed for the percutaneous, intraoperative coagulation, and ablation of soft tissue, addressing conditions such as non-resectable liver lesions.<\/p>\n Tumor Ablation Therapy Devices Market Segmentation<\/a> Regional Dynamics: North America Leads, Asia-Pacific Follows<\/p>\n In 2023, North America emerged as the largest region in the tumor ablation therapy devices market, driven by a robust healthcare infrastructure and increasing adoption of advanced medical technologies. Asia-Pacific secured the second-largest position, reflecting a growing awareness of minimally invasive cancer treatments and rising healthcare investments in the region.<\/p>\n Access the Complete Report for In-Depth Analysis: Tumor Ablation Therapy Devices Global Market Report 2023 from TBRC covers the following information: Trends, opportunities, strategies and so much more.<\/p>\n The Tumor Ablation Therapy Devices Global Market Report 2023 by The Business Research Company<\/a> is the most comprehensive report that provides insights on tumor ablation therapy devices market size, tumor ablation therapy devices market drivers and trends, tumor ablation therapy devices market major players, tumor ablation therapy devices market competitors’ revenues, tumor ablation therapy devices market positioning, and tumor ablation therapy devices market growth across geographies. The tumor ablation therapy devices market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.<\/p>\n Browse Through More Similar Reports By The Business Research Company: Solid Tumor Cancer Treatment Global Market Report 2023 Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2023 About The Business Research Company Global Market Model \u2013 Market Intelligence Database Contact Information Check out our: Oliver Guirdham Explore the Exciting Growth Potential of the Automotive Voice Recognition System Market<\/p>\n \n
https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=3351&type=smp<\/a><\/p>\n
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users <\/p>\n
https:\/\/www.thebusinessresearchcompany.com\/report\/tumor-ablation-therapy-devices-global-market-report<\/a><\/p>\n
\u2022 Market size date for the forecast period: Historical and Future
\u2022 Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
\u2022 Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.<\/p>\n
Tumor Embolization Devices Global Market Report 2023
https:\/\/www.thebusinessresearchcompany.com\/report\/tumor-embolization-devices-global-market-report<\/a><\/p>\n
https:\/\/www.thebusinessresearchcompany.com\/report\/solid-tumor-cancer-treatment-global-market-<\/a><\/p>\n
https:\/\/www.thebusinessresearchcompany.com\/report\/tumor-necrosis-factor-inhibitor-drugs-global-market-report<\/a><\/p>\n
The Business Research Company has published over 3000+ detailed industry reports, spanning over 6500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.<\/p>\n
The Global Market Model, The Business Research Company\u2019s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.<\/p>\n
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info<\/p>\n
LinkedIn: https:\/\/in.linkedin.com\/company\/the-business-research-company<\/a>
Twitter: https:\/\/twitter.com\/tbrc_info<\/a>
Facebook: https:\/\/www.facebook.com\/TheBusinessResearchCompany<\/a>
YouTube: https:\/\/www.youtube.com\/channel\/UC24_fI0rV8cR5DxlCpgmyFQ<\/a>
Blog: https:\/\/blog.tbrc.info\/<\/a>
Healthcare Blog: https:\/\/healthcareresearchreports.com\/<\/a>
Global Market Model: https:\/\/www.thebusinessresearchcompany.com\/global-market-model<\/a> <\/p>\n
The Business Research Company
+44 20 7193 0708<\/a>
info@tbrc.info<\/a>
Visit us on social media:
Facebook<\/a>
Twitter<\/a>
LinkedIn<\/a><\/p>\n